ClinVar Miner

Submissions for variant NM_001271208.2(NEB):c.4435G>A (p.Val1479Ile) (rs34577613)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000117759 SCV000269430 benign not specified 2014-11-26 criteria provided, single submitter clinical testing p.Val1479Ile in exon 38 of NEB: This variant is not expected to have clinical si gnificance because it has been identified in 36% (1503/4208) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs34577613).
PreventionGenetics,PreventionGenetics RCV000117759 SCV000307355 benign not specified criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000402157 SCV000417000 benign Nemaline myopathy 2 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000117759 SCV000519517 benign not specified 2016-01-28 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000588052 SCV000697831 benign not provided 2017-04-24 criteria provided, single submitter clinical testing Variant summary: The NEB c.4435G>A (p.Val1479Ile) variant involves the alteration of a non-conserved nucleotide and 4/4 in silico tools (SNPs&GO not captured due to low reliability index) predict a benign outcome. This variant was found in 22922/120734 control chromosomes (including 3255 homozygotes) from ExAC at a frequency of 0.1898554, which is approximately 54 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), thus this variant is a commom benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as "likely benign/benign." Therefore, the variant of interest has been classified as Benign.
Athena Diagnostics Inc RCV000588052 SCV001144724 benign not provided 2019-03-07 criteria provided, single submitter clinical testing
Genetic Services Laboratory,University of Chicago RCV000117759 SCV000152015 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.